Alnylam Pharmaceuticals Completes $661.25 Million Convertible Senior Notes Offering

Ropes & Gray has advised Alnylam Pharmaceuticals on the transaction, and Davis Polk has advised the initial purchasers and the counterparties to the capped call transactions.Alnylam…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here